Your browser doesn't support javascript.
loading
Three-dose vaccination elicits neutralising antibodies against omicron.
Wu, Mary; Wall, Emma C; Carr, Edward J; Harvey, Ruth; Townsley, Hermaleigh; Mears, Harriet V; Adams, Lorin; Kjaer, Svend; Kelly, Gavin; Warchal, Scott; Sawyer, Chelsea; Kavanagh, Caitlin; Queval, Christophe J; Ngai, Yenting; Hatipoglu, Emine; Ambrose, Karen; Hindmarsh, Steve; Beale, Rupert; Gamblin, Steve; Howell, Michael; Kassiotis, George; Libri, Vincenzo; Williams, Bryan; Gandhi, Sonia; Swanton, Charles; Bauer, David Lv.
Afiliação
  • Wu M; The Francis Crick Institute, London NW1 1AT, UK.
  • Wall EC; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK.
  • Carr EJ; The Francis Crick Institute, London NW1 1AT, UK.
  • Harvey R; Worldwide Influenza Centre, The Francis Crick Institute, London, UK.
  • Townsley H; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK.
  • Mears HV; The Francis Crick Institute, London NW1 1AT, UK.
  • Adams L; Worldwide Influenza Centre, The Francis Crick Institute, London, UK.
  • Kjaer S; The Francis Crick Institute, London NW1 1AT, UK.
  • Kelly G; The Francis Crick Institute, London NW1 1AT, UK.
  • Warchal S; The Francis Crick Institute, London NW1 1AT, UK.
  • Sawyer C; The Francis Crick Institute, London NW1 1AT, UK.
  • Kavanagh C; The Francis Crick Institute, London NW1 1AT, UK.
  • Queval CJ; The Francis Crick Institute, London NW1 1AT, UK.
  • Ngai Y; University College London, London, UK.
  • Hatipoglu E; University College London, London, UK.
  • Ambrose K; The Francis Crick Institute, London NW1 1AT, UK.
  • Hindmarsh S; The Francis Crick Institute, London NW1 1AT, UK.
  • Beale R; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Gamblin S; The Francis Crick Institute, London NW1 1AT, UK.
  • Howell M; The Francis Crick Institute, London NW1 1AT, UK.
  • Kassiotis G; The Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
  • Libri V; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Williams B; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Gandhi S; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Swanton C; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Bauer DL; The Francis Crick Institute, London NW1 1AT, UK. Electronic address: david.bauer@crick.ac.uk.
Lancet ; 399(10326): 715-717, 2022 02 19.
Article em En | MEDLINE | ID: mdl-35065005
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido